MedPath

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States
Ownership
-
Established
1943-01-01
Employees
8.1K
Market Cap
-
Website
http://www.utsouthwestern.edu

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

Phase 2
Recruiting
Conditions
Breast Cancer
Interventions
Drug: Pembrolizumab
Procedure: Core Biopsy/Cryoablation
Procedure: Breast Surgery
Drug: Ipilimumab
Drug: Nivolumab
First Posted Date
2018-06-06
Last Posted Date
2024-07-24
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
80
Registration Number
NCT03546686
Locations
🇺🇸

Cedars Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Ohio State University Medical Center, Columbus, Ohio, United States

🇺🇸

Providence Cancer Institute, Portland, Oregon, United States

and more 1 locations

Biological Effect of Warfarin on Pancreatic Cancer

Early Phase 1
Withdrawn
Conditions
Pancreatic Cancer
Interventions
First Posted Date
2018-05-24
Last Posted Date
2021-03-25
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT03536208
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

Phase 3
Withdrawn
Conditions
Locally Advanced Pancreatic Adenocarcinoma
Interventions
Radiation: Carbon Ion Radiation Therapy (CIRT)
Radiation: Intensity Modulated Radiation Therapy (IMRT)
First Posted Date
2018-05-24
Last Posted Date
2021-05-26
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT03536182
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

🇯🇵

National Institute of Radiological Sciences,4-9-1, Anagawa, Inage-ku,, Chiba, Japan

Implementing an IPTS Treatment Approach to Improve Outcomes in Suicidal Youth

Not Applicable
Completed
Conditions
Suicidal Ideation
Depression
Interventions
Behavioral: SPARC A
Behavioral: SPARC B
First Posted Date
2018-05-17
Last Posted Date
2019-11-01
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
123
Registration Number
NCT03527459
Locations
🇺🇸

Children's Medical Center, Dallas, Texas, United States

Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)

Phase 2
Active, not recruiting
Conditions
Prostate Cancer Adenocarcinoma
Interventions
Radiation: 30Gy (Gray) planning target volume (PTV)
First Posted Date
2018-05-15
Last Posted Date
2024-05-21
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
124
Registration Number
NCT03525262
Locations
🇺🇸

UT Southwestern Cancer Center, Dallas, Texas, United States

🇺🇸

Penrose Hospital, Colorado Springs, Colorado, United States

🇺🇸

Stony Brook University Cancer Center, Stony Brook, New York, United States

and more 5 locations

Transfusion of Whole Blood and Cesarean Delivery: A Retrospective Review

Completed
Conditions
Obstetric Labor Complications
First Posted Date
2018-05-14
Last Posted Date
2020-05-19
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
1500
Registration Number
NCT03523780
Locations
🇺🇸

Parkland Hospital, Dallas, Texas, United States

Neurocognitive Decline in Patients With Brain Metastases

Phase 1
Recruiting
Conditions
Brain Metastases
Interventions
Radiation: Stereotactic Radiosurgery
First Posted Date
2018-04-26
Last Posted Date
2024-04-10
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
80
Registration Number
NCT03508752
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Radio Frequency Microneedling for Suprapatellar Skin

Not Applicable
Completed
Conditions
Skin Laxity
Interventions
Device: Profound system
First Posted Date
2018-04-24
Last Posted Date
2020-12-03
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
20
Registration Number
NCT03507036
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

A Neurosteroid Intervention for Menopausal and Perimenopausal Depression

Phase 1
Active, not recruiting
Conditions
Major Depressive Disorder
Menopause
Perimenopause
Interventions
Drug: Pregnenolone
Drug: Placebo
First Posted Date
2018-04-23
Last Posted Date
2024-12-19
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
123
Registration Number
NCT03505905
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

Imaging of Traumatic Brain Injury Metabolism Using Hyperpolarized Carbon-13 Pyruvate

Early Phase 1
Conditions
Traumatic Brain Injury
Interventions
Drug: Hyperpolarized [1-13C] Pyruvate
Drug: Hyperpolarized [2-13C] Pyruvate
First Posted Date
2018-04-19
Last Posted Date
2023-09-15
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
60
Registration Number
NCT03502967
Locations
🇺🇸

UT Southwestern - Advanced Imaging Research Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath